Home › NDC Lookup › Drug shortages › Morphine Sulfate Suppository

Morphine Sulfate Suppository shortage

Morphine Sulfate Suppository is currently listed in shortage by the FDA. The FDA lists 4 affected products. This page was last refreshed from FDA data on Oct 1, 2026.

To Be Discontinued ⚠ Supply risk: High Controlled substance Analgesia/Addiction 4 products 70 days First posted Jul 23, 2026 Updated Jul 23, 2026
Here’s the bottom line

Padagis is permanently stopping production of morphine sulfate suppositories, including the 5 mg, 10 mg, 20 mg, and 30 mg strengths. No other manufacturers of this product are currently listed as having supply available.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
4
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/4
Affected strengths supplied
70
Days in shortage
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 1, 2026 · yesterday

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Morphine Sulfate Suppository. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
4 NDCs
To be discontinued 4
Affected strengths still supplied
Among manufacturers reporting this shortage
0/4 strengths
No supply 4
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Morphine Sulfate Suppository from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Plus 17 alternative dosage forms of Morphine Sulfate.
See all other options & details →
Shortage timeline
  1. Jul 23, 2026
    Currently in shortage
    4 of 4 products affected.
  2. Jul 23, 2026
    First reported to the FDA
    4 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Padagis US LLC 📞 (800) 775-2054 4 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Morphine Sulfate, Suppository, 10 mg (NDC 0574-7112-12) NDC 00574-7112-12 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Morphine Sulfate, Suppository, 5 mg (NDC 0574-7110-12) NDC 00574-7110-12 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Morphine Sulfate, Suppository, 30 mg (NDC 0574-7116-12) NDC 00574-7116-12 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Morphine Sulfate, Suppository, 20 mg (NDC 0574-7114-12) NDC 00574-7114-12 — — Discontinuation of the manufacture of the drug —

These rows are manufacturer reports to the FDA for Morphine Sulfate Suppository — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Morphine Sulfate Suppository? options further down this page.

Why is Morphine Sulfate Suppository in shortage?

Padagis US LLC has reported to the FDA that they are permanently stopping the manufacturing of their morphine sulfate suppositories — this affects all four strengths they made: the 5 mg, 10 mg, 20 mg, and 30 mg suppositories. This isn't a temporary shortage or a factory delay — it's a permanent decision by Padagis to stop making these products altogether.

It's worth knowing that Padagis did not share a specific public reason why they made this decision — just that the manufacturing is being discontinued. This report reflects only what Padagis has filed with the FDA, so it speaks only to their products and not to what other manufacturers may be doing.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Morphine Sulfate Suppository, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Morphine Sulfate Suppository?

Morphine Sulfate Suppository is currently on the FDA drug-shortage list, and I want to walk you through what that means for you.

All four strengths reported to the FDA — the 5 mg, 10 mg, 20 mg, and 30 mg — have no available source at this time. In this record, the manufacturer (Padagis US LLC) has listed each strength as being discontinued. Because this is marked "to be discontinued," this supply problem may be permanent rather than a short pause, so planning ahead with your care team is the right next step.

I know this is not easy to read, especially if this medicine is part of your pain care. Please do not stop or change your dose on your own — that can cause real harm.

Here is what I suggest:

  • Reach out to your prescriber or pharmacist soon to talk about options, since this product is being discontinued and there are no other makers listed here.
  • Ask whether a clinician-chosen alternative or a different approach to your dose would be appropriate for you.
  • The manufacturer's contact number is listed on this page for reference, though your pharmacy usually handles those calls.

This information comes from national, manufacturer-reported FDA data and may not match your local pharmacy's stock. Your care team can guide the best path forward for you.

See “Where else can I get Morphine Sulfate Suppository?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
  • This is a controlled substance. Transfers between pharmacies and switching strengths have extra federal/state rules — ask the pharmacy before you assume a transfer is possible.
Keep reading
Our full Morphine Rectal guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Morphine Rectal guide →

Where else can I get Morphine Sulfate Suppository?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Morphine Sulfate Suppository is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Alternative dosage forms of Morphine Sulfate

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 6 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Morphine Sulfate 10 mgNDC 00574-7112-12 Padagis 12 suppositories — — FDA listed
Morphine Sulfate 10 mgNDC 63629-2535-01 Bryant 12 suppositories — — FDA listed
Morphine Sulfate 5 mgNDC 00574-7110-12 Padagis 12 suppositories — — FDA listed
Morphine Sulfate 5 mgNDC 63629-2537-01 Bryant 12 suppositories — — FDA listed
Morphine Sulfate 30 mgNDC 00574-7116-12 Padagis 12 suppositories — — FDA listed
Morphine Sulfate 30 mgNDC 63629-2538-01 Bryant 12 suppositories — — FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Morphine Sulfate Suppository — that fall in the same broad treatment class (opioid analgesics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 004083
GCN 16051
HICL code 001694
Ingredient (HICL) Morphine Sulfate
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H3
Therapeutic class — intermediate (HIC2) Analgesics
HIC3 code H3A
Therapeutic class — specific (HIC3) Opioid Analgesics
AHFS code 28:08.08.00
AHFS class Opioid Agonists (28:08)
FDB label name MORPHINE SULF 10 MG SUPPOS
FDB brand name Morphine Sulfate
Legend status F — Federal legend — prescription drug or device
GPI-1465100055105210
GPI classMorphine Sulfate
DEA scheduleCII
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other analgesia/addiction shortages

Morphine Sulfate Suppository shortage FAQs

Is Morphine Sulfate Suppository in shortage?
Yes — the FDA currently lists Morphine Sulfate Suppository in shortage (status: “To Be Discontinued”, first reported Jul 23, 2026). 4 of 4 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
Morphine Sulfate, Suppository, 10 mg (NDC 0574-7112-12) (NDC 00574-7112-12); Morphine Sulfate, Suppository, 5 mg (NDC 0574-7110-12) (NDC 00574-7110-12); Morphine Sulfate, Suppository, 30 mg (NDC 0574-7116-12) (NDC 00574-7116-12). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Morphine Sulfate Suppository be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Morphine Sulfate somewhere?
17 alternative dosage forms of Morphine Sulfate are also listed. See “Where else can I get Morphine Sulfate Suppository?” above — stock still varies by pharmacy.
What should I do if I take Morphine Sulfate Suppository?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out. Because this is a controlled substance, transfers and substitutions have extra federal/state rules — ask the pharmacy first.

Still have a question about the Morphine Sulfate Suppository shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages